• About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: DEPRESSION

New drug approvals in 2020

February 5, 2020  

Antidepressants – mixed scorecard in 2019

December 19, 2019  

Future look: Drug approvals pending for 2020

December 5, 2019  

FDA advisors recommend intranasal ketamine in depression

February 20, 2019  

Always online: problem or addiction?

February 13, 2019  

Comorbidity – a publishing phenomenon

February 14, 2018  

Vortioxetine: Improved work productivity in adults with major depression

December 13, 2017  

Adversity, hunger and early-life depression: 2 reports

March 22, 2017  

APA highlights: Treatment trials in psychiatry

June 22, 2016  

Weight gain common with some antidepressant combinations

June 1, 2016  
1
2
3
4

Browse by Topic

MS (268)
AD (81)
PD (77)
PREVIOUS CONGRESSES (37)
DEPRESSION (36)
MIGRAINE (26)
SCHIZOPHRENIA (25)
STROKE (22)
EPILEPSY (21)
COVID-19 (16)
ECTRIMS 2015 (13)
AAN 2015 (11)
ECTRIMS 2014 (10)
DEMENTIA (10)
ECTRIMS 2018 (10)
ECTRIMS 2019 (10)
ECTRIMS 2013 (9)
AAN 2014 (9)
MS SEQUENCING (9)
AAN 2013 (9)
PSYCHIATRY (8)
AAN 2019 (7)
ACTRIMS-ECTRIMS 2020 (7)
ECTRIMS 2017 (7)
ECTRIMS 2016 (6)
CHARCOT 2013 (6)
CCSVI (5)
BIPOLAR (5)
ANXIETY (5)
AAN 2017 (4)
EAN 2015 (4)
BPD (4)
NeuroSound (4)
AAN 2018 (3)
PAIN (3)
ENS 2013 (3)
AAN 2020 (3)
APA 2014 (2)
EAN 2020 (2)
SPECIAL REPORT (2)
SLEEP (2)
NEW DRUGS (2)
AAN 2016 (2)
ADDICTION (1)
EAN 2019 (1)
LUMBAR PUNCTURE (1)
CONCUSSION (1)
CIDP (1)
Dravet syndrome (1)
hATTR (1)
ALS (1)
SEIZURE (1)
INSOMNIA (1)
WEST NILE (1)
LGS (1)
APA 2016 (1)
EAN 2016 (1)
GUIDELINES (1)
TSC (1)
ECTRIMS 2020 (0)
View all Topics

Popular Posts

  • Multiple sclerosis 2021 – a look ahead posted on January 13, 2021
  • Progression independent of relapses (PIRA) in MS posted on November 21, 2019
  • Ozanimod vs. fingolimod: is there a difference? posted on November 13, 2020
Copyright 2021 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions